[ad_1]
US regulators on Friday approved the first drug created specifically to reduce excessive sweating, a common condition that can cause distress and affect social life. a person
. ] The Food and Drug Administration (FDA for its acronym in English) approved the drug Qbrexza against excessive sweat in the armpits which is on sale in October . The drug is found in a tissue that is rubbed daily on the skin to block the activation of the sweat glands.
The manufacturer, Dermira Inc., declined to disclose the price, as these companies normally do.
It is estimated that about 15.3 million Americans suffer from excessive sweating, but only one in four requires treatment. Current treatments include Botox injections, elimination of sweat glands by surgical means, laser and other devices and drugs approved for other disorders that block the chemical messengers of the body to reduce sweat production in the whole body.
Collateral Effects of Qbrexza Include Blurred vision, constipation, burning or itching of the skin, headache or throat and dryness of the mouth, eyes and skin
Dermira stated that in a study, 53% of patients reported that Qbrexza reduced sweating by half while in the comparison group, provided with drug-free wipes, he was reduced in the 28% of cases.
We give you an answer within 48 hours and you can have money in less than 10 www.premo.mx
[ad_2]
Source link
